ZyVersa Therapeutics Statistics

Total Valuation

ZVSA has a market cap or net worth of $1.38 million. The enterprise value is -$128,629.

Market Cap	1.38M
Enterprise Value	-128,629

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ZVSA has 2.34 million shares outstanding. The number of shares has increased by 1,038.50% in one year.

Current Share Class	2.34M
Shares Outstanding	2.34M
Shares Change (YoY)	+1,038.50%
Shares Change (QoQ)	+101.47%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	4.42%
Float	2.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.86

Financial Efficiency

Return on equity (ROE) is -96.10% and return on invested capital (ROIC) is -58.27%.

Return on Equity (ROE)	-96.10%
Return on Assets (ROA)	-26.74%
Return on Invested Capital (ROIC)	-58.27%
Return on Capital Employed (ROCE)	-97.53%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ZVSA has paid $6,745 in taxes.

Income Tax	6,745
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.02% in the last 52 weeks. The beta is 0.47, so ZVSA's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-92.02%
50-Day Moving Average	1.08
200-Day Moving Average	2.11
Relative Strength Index (RSI)	27.68
Average Volume (20 Days)	424,731

Short Selling Information

The latest short interest is 187,928, so 8.02% of the outstanding shares have been sold short.

Short Interest	187,928
Short Previous Month	44,416
Short % of Shares Out	8.02%
Short % of Float	8.04%
Short Ratio (days to cover)	0.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.14M
Pretax Income	-22.42M
Net Income	-9.41M
EBITDA	-9.13M
EBIT	-9.14M
Earnings Per Share (EPS)	-$8.48

Full Income Statement

Balance Sheet

The company has $1.53 million in cash and n/a in debt, giving a net cash position of $1.53 million or $0.65 per share.

Cash & Cash Equivalents	1.53M
Total Debt	n/a
Net Cash	1.53M
Net Cash Per Share	$0.65
Equity (Book Value)	8.52M
Book Value Per Share	3.40
Working Capital	-9.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZVSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,038.50%
Shareholder Yield	-1,038.50%
Earnings Yield	-671.29%
FCF Yield	n/a

Analyst Forecast

The average price target for ZVSA is $240.00, which is 40,751.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$240.00
Price Target Difference	40,751.06%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Apr 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1